You are here: Home Products illumina Uncategorised Clinical


Advancements in genetic analysis are revolutionizing the practice of medicine, improving prenatal and reproductive care, enabling earlier disease detection, and advancing treatment of heritable disease. Novel assays based on next-generation sequencing and microarray technologies are being developed, helping us unlock the power of the genome. When laboratories begin to take advantage of these tools, we will see changes in healthcare in ways never before imagined. Ultimately, paving the way to improving human health


We are committed to helping translational and clinical researchers uncover new insights into the biology of cancer that can lead to meaningful advances in its identification and treatment. Our complete, seamless workflow solutions help researchers achieve deeper and more accurate analysis of a tumor’s molecular profile and accelerate the development of cancer companion diagnostics. Partner with us to help propel progress in personalized oncology.






With the sensitivity, accuracy, and speed of our NGS solutions, researchers can more rapidly identify causative variants of inherited disorders by assessing many genes at the same time. The more we know, the more we can do.




High-resolution, unambiguous human leukocyte antigen (HLA) typing with NGS enables researchers to interrogate more of the HLA region. The goal is to reduce the need for additional testing so donor recipients can benefit from more expedient matching.



Our Partners


Bio-Active Co., Ltd. 
188/1 Bio-Active Bldg., Soi Sirung,
Chua Phloeng Rd., Chongnonsi,
Yannawa Bangkok 10120 



บริษัท ไบโอแอคทีฟ จำกัด
188/1 อาคารไบโอแอคทีฟ ซอยศรีรุ้ง
ถนนเชื้อเพลิง แขวงช่องนนทรี
เขตยานนาวา กรุงเทพฯ 10120


  • Hot line: 66-2350-3090
    FAX : 66-2350-3091


You are here: Home Products illumina Uncategorised Clinical